Pacira BioSciences Inc (PCRX)
27.21
-0.11
(-0.40%)
USD |
NASDAQ |
May 03, 16:00
27.22
+0.01
(+0.04%)
After-Hours: 20:00
Pacira BioSciences Revenue (TTM): 674.98M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 674.98M |
| September 30, 2023 | 665.69M |
| June 30, 2023 | 669.23M |
| March 31, 2023 | 669.17M |
| December 31, 2022 | 666.82M |
| September 30, 2022 | 654.06M |
| June 30, 2022 | 614.32M |
| March 31, 2022 | 580.50M |
| December 31, 2021 | 541.53M |
| September 30, 2021 | 513.31M |
| June 30, 2021 | 503.08M |
| March 31, 2021 | 442.99M |
| December 31, 2020 | 429.65M |
| September 30, 2020 | 421.10M |
| June 30, 2020 | 408.30M |
| March 31, 2020 | 435.40M |
| December 31, 2019 | 421.03M |
| September 30, 2019 | 393.72M |
| June 30, 2019 | 372.48M |
| March 31, 2019 | 353.98M |
| December 31, 2018 | 337.28M |
| September 30, 2018 | 321.24M |
| June 30, 2018 | 305.13M |
| March 31, 2018 | 291.95M |
| December 31, 2017 | 286.63M |
| Date | Value |
|---|---|
| September 30, 2017 | 280.45M |
| June 30, 2017 | 281.47M |
| March 31, 2017 | 280.18M |
| December 31, 2016 | 276.37M |
| September 30, 2016 | 272.79M |
| June 30, 2016 | 266.65M |
| March 31, 2016 | 256.16M |
| December 31, 2015 | 249.00M |
| September 30, 2015 | 241.47M |
| June 30, 2015 | 231.30M |
| March 31, 2015 | 219.32M |
| December 31, 2014 | 197.67M |
| September 30, 2014 | 169.44M |
| June 30, 2014 | 140.65M |
| March 31, 2014 | 110.63M |
| December 31, 2013 | 85.55M |
| September 30, 2013 | 62.44M |
| June 30, 2013 | 47.66M |
| March 31, 2013 | 42.87M |
| December 31, 2012 | 39.08M |
| September 30, 2012 | 32.87M |
| June 30, 2012 | 28.34M |
| March 31, 2012 | 19.63M |
| December 31, 2011 | 15.69M |
| September 30, 2011 | 13.65M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
372.48M
Minimum
Jun 2019
674.98M
Maximum
Dec 2023
530.39M
Average
513.31M
Median
Sep 2021
Revenue (TTM) Benchmarks
| Dynavax Technologies Corp | 232.28M |
| Arbutus Biopharma Corp | 18.14M |
| Chimerix Inc | 0.324M |
| Karyopharm Therapeutics Inc | 146.03M |
| FibroGen Inc | 147.75M |